MiNK Therapeutics Ownership & Insider Activity

MiNK Therapeutics (INKT) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 45.1% of shares outstanding. Institutional investors hold 3.8%.

Shares Outstanding

5.103M

Shares Float

2.555M

Insider Shares Owned

2.299M

Insider % Owned

45.1%

Institutional Shares Held

194.146K

Institutional % Held

3.8%

Ownership Breakdown

Net Insider Activity by Month

MiNK Therapeutics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Oct 11, 2026	Jennifer Buell	CHIEF EXECUTIVE OFFICER	SELL-OPTIONS	16.253K	$10.56	$73K
Jun 4, 2026	Barbara Ryan	—	SELL	1.500K	$12.76	$19K